Mama's Creations, Inc. - Quarter Report: 2014 April (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarter ended: April 30, 2014
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period from ___________ to ____________
Commission File Number: 333-150029
MamaMancini’s Holdings, Inc.
(Exact name of Registrant as specified in its charter)
Nevada | 27-067116 | |
(State or other jurisdiction of incorporation) | (IRS Employer I.D. No.) |
25 Branca Road
East Rutherford, NJ 07073
(Address of principal executive offices and zip Code)
(201) 531-1212
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months, and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files. Yes [X] No [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:
Large accelerated filer | [ ] | Accelerated filer | [ ] | |
Non-accelerated filer | [ ] | Smaller reporting company | [X] |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X]
As of June 12, 2014, there were 25,807,376 shares outstanding of the registrant’s common stock.
TABLE OF CONTENTS
PART I – FINANCIAL INFORMATION | |||
Item 1. | Financial Statements. | 3 | |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations. | 5 | |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk. | 11 | |
Item 4. | Controls and Procedures. | 11 | |
PART II – OTHER INFORMATION | |||
Item 1. | Legal Proceedings. | 12 | |
Item 1A. | Risk Factors. | 12 | |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds. | 12 | |
Item 3. | Defaults Upon Senior Securities. | 12 | |
Item 4. | Mine Safety Disclosures. | 12 | |
Item 5. | Other Information. | 12 | |
Item 6. | Exhibits. | 12 | |
Signatures | 13 |
2 |
PART I - FINANCIAL INFORMATION
MAMAMANCINI’S HOLDINGS, INC.
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
APRIL 30, 2014
3 |
MAMAMANCINI’S HOLDINGS, INC.
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
APRIL 30, 2014
Table of Contents
4 |
Condensed Consolidated Balance Sheets
April 30, 2014 | January 31, 2014 | |||||||
(unaudited) | ||||||||
Assets | ||||||||
Assets: | ||||||||
Cash | $ | 1,079,688 | $ | 1,541,640 | ||||
Accounts receivable, net | 1,143,943 | 1,029,632 | ||||||
Inventories | 404,116 | 159,829 | ||||||
Prepaid expenses | 153,666 | 140,511 | ||||||
Due from manufacturer - related party | 758,861 | 774,049 | ||||||
Deposit with manufacturer - related party | 762,743 | 598,987 | ||||||
Total current assets | 4,303,017 | 4,244,648 | ||||||
Property and equipment, net | 1,044,757 | 978,027 | ||||||
Debt issuance costs, net | 46,658 | 46,264 | ||||||
Total Assets | $ | 5,394,432 | $ | 5,268,939 | ||||
Liabilities and Stockholders’ Equity | ||||||||
Liabilities: | ||||||||
Accounts payable and accrued expenses | $ | 583,878 | $ | 595,297 | ||||
Line of credit | 203,733 | 222,704 | ||||||
Total current liabilities | 787,611 | 818,001 | ||||||
Commitments and contingencies | ||||||||
Stockholders’ Equity | ||||||||
Preferred stock, $0.00001 par value; 20,000,000 shares authorized; no shares issued and outstanding | - | - | ||||||
Common stock, $0.00001 par value; 250,000,000 shares authorized; 25,020,708 and 24,187,375 shares issued and outstanding, respectively | 250 | 242 | ||||||
Additional paid in capital | 11,850,738 | 10,993,973 | ||||||
Common stock subscribed, $0.00001 par value; 653,334 and 833,333 shares, respectively | 7 | 8 | ||||||
Accumulated deficit | (7,244,174 | ) | (6,543,285 | ) | ||||
Total Stockholders’ Equity | 4,606,821 | 4,450,938 | ||||||
Total Liabilities and Stockholders’ Equity | $ | 5,394,432 | $ | 5,268,939 |
See accompanying notes to the condensed consolidated financial statements
F-1 |
Condensed Consolidated Statements of Operations
For the Three Months Ended | For the One Month Ended | |||||||||||
April 30, 2014 | March 31, 2013 | January 31, 2014 | ||||||||||
(unaudited) | (unaudited) | |||||||||||
Sales - net of slotting fees and discounts | $ | 2,583,149 | $ | 1,772,164 | $ | 775,252 | ||||||
Cost of sales | 1,780,225 | 1,282,102 | 535,870 | |||||||||
Gross profit | 802,924 | 490,062 | 239,382 | |||||||||
Operating expenses | ||||||||||||
Research and development | 18,901 | 3,143 | 8,477 | |||||||||
General and administrative expenses | 1,468,278 | 1,096,057 | 472,023 | |||||||||
Total operating expenses | 1,487,179 | 1,099,200 | 480,500 | |||||||||
Loss from operations | (684,255 | ) | (609,138 | ) | (241,118 | ) | ||||||
Other income (expenses) | ||||||||||||
Interest expense | (16,634 | ) | (2,250 | ) | (2,526 | ) | ||||||
Total other income (expense) | (16,634 | ) | (2,250 | ) | (2,526 | ) | ||||||
Net loss | $ | (700,889 | ) | $ | (611,388 | ) | $ | (243,644 | ) | |||
Net loss per common share - basic and diluted | $ | (0.03 | ) | $ | (0.03 | ) | $ | (0.01 | ) | |||
Weighted average common shares outstanding -basic and diluted | 24,711,719 | 20,640,667 | 24,187,375 |
See accompanying notes to the condensed consolidated financial statements
F-2 |
Condensed Consolidated Statement of Changes in Stockholders’ Equity
For the Period February 1, 2014 through April 30, 2014
(unaudited)
Common Stock | Additional | Common Stock | Accumulated | Stockholders’ | ||||||||||||||||||||
Shares | Amount | Paid In Capital | Subscribed | Deficit | Equity | |||||||||||||||||||
Balance, February 1, 2014 | 24,187,375 | $ | 242 | $ | 10,993,973 | 8 | $ | (6,543,285 | ) | $ | 4,450,938 | |||||||||||||
Stock options issued for services | - | - | 4,172 | - | - | 4,172 | ||||||||||||||||||
Warrants issued for services | - | - | 94,927 | - | - | 94,927 | ||||||||||||||||||
Common stock issued | 833,333 | 8 | - | (8 | ) | - | ||||||||||||||||||
Common stock subscribed, 653,335 shares | - | - | 979,994 | 7 | - | 980,001 | ||||||||||||||||||
Stock issuance costs | - | - | (222,327 | ) | - | - | (222,327 | ) | ||||||||||||||||
Net loss for the three months ended April 30, 2014 | - | - | - | - | (700,889 | ) | (700,889 | ) | ||||||||||||||||
Balance, April 30, 2014 | 25,020,708 | 250 | 11,850,739 | 7 | (7,244,174 | ) | 4,606,822 |
See accompanying notes to the condensed consolidated financial statements
F-3 |
Condensed Consolidated Statements of Cash Flows
For the Three Months Ended | For the One Month Ended | |||||||||||
April 30, 2014 | March 31, 2013 | January 31, 2014 | ||||||||||
(unaudited) | (unaudited) | |||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||||||
Net loss | $ | (700,889 | ) | $ | (611,388 | ) | (243,644 | ) | ||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||||||
Depreciation | 14,737 | 3,260 | 4,141 | |||||||||
Amortization of debt issuance costs | 4,091 | - | 1,322 | |||||||||
Share-based compensation | 4,172 | - | 2,015 | |||||||||
Changes in operating assets and liabilities: | ||||||||||||
(Increase) Decrease in: | ||||||||||||
Accounts receivable | (114,311 | ) | (350,021 | ) | 34,217 | |||||||
Inventory | (244,287 | ) | (22,525 | ) | (47,550 | ) | ||||||
Prepaid expenses | (13,155 | ) | (71,628 | ) | (4,986 | ) | ||||||
Due from manufacturer - related party | 15,188 | - | 7,472 | |||||||||
Deposit with manufacturer - related party | (163,756 | ) | (30,904 | ) | (239,481 | ) | ||||||
Increase (Decrease) in: | ||||||||||||
Accounts payable and accrued expenses | (11,420 | ) | 136,028 | (227,747 | ) | |||||||
Due to manufacturer - related party | - | (67,803 | ) | - | ||||||||
Net Cash Used In Operating Activities | (1,209,630 | ) | (1,014,981 | ) | (714,241 | ) | ||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||||||
Cash paid for machinery and equipment | (81,467 | ) | - | (52,672 | ) | |||||||
Cash paid for acquisition of shell company | - | (295,000 | ) | - | ||||||||
Loans to related party | - | (30,000 | ) | - | ||||||||
Net Cash Used In Investing Activities | (81,467 | ) | (325,000 | ) | (52,672 | ) | ||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||||||
Stock issuance costs | (127,400 | ) | - | (58,500 | ) | |||||||
Proceeds from common stock subscribed | 980,001 | - | 450,000 | |||||||||
Debt issuance costs | (4,485 | ) | - | (47,586 | ) | |||||||
Borrowings from line of credit, net | (18,971 | ) | - | 222,704 | ||||||||
Net Cash Provided By Financing Activities | 829,145 | - | 566,618 | |||||||||
Net Decrease in Cash | (461,952 | ) | (1,339,981 | ) | (200,295 | ) | ||||||
Cash - Beginning of Period | 1,541,640 | 2,008,161 | 1,741,935 | |||||||||
Cash - End of Period | $ | 1,079,688 | $ | 668,180 | $ | 1,541,640 | ||||||
SUPPLEMENTARY CASH FLOW INFORMATION: | ||||||||||||
Cash Paid During the Period for: | ||||||||||||
Income taxes | $ | - | $ | - | - | |||||||
Interest | $ | 16,634 | $ | 2,250 | 8,640 | |||||||
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||||||||||||
Stock issuance costs paid in the form of warrants | $ | 94,927 | $ | - | 43,166 |
See accompanying notes to the condensed consolidated financial statements
F-4 |
Notes to Condensed Consolidated Financial Statements
April 30, 2014
Note 1 – Nature of Operations and Basis of Presentation
Nature of Operations
MamaMancini’s Holdings, Inc. (the “Company”), (formerly known as Mascot Properties, Inc.) was organized on July 22, 2009 as a Nevada corporation.
Current Business of the Company
The Company is a manufacturer and distributor of a line of beef meatballs with sauce, turkey meatballs with sauce, Italian sausage with sauce and other similar Italian meats with sauces. The Company’s customers are located throughout the United States, with a large concentration in the Northeastern and Southeastern United States regions.
Mergers
On January 24, 2013, the Company, Mascot Properties Acquisition Corp, a Delaware corporation and wholly-owned subsidiary of the Company (“Merger Sub”), MamaMancini’s, Inc., a privately-held Delaware Corporation headquartered in New Jersey (“MamaMancini’s”) and an individual (the “Majority Shareholder”), entered into an Acquisition Agreement and Plan of Merger (the “Agreement”) pursuant to which the Merger Sub was merged with and into MamaMancini’s, with MamaMancini’s surviving as a wholly-owned subsidiary of the Company (the “Merger”). The Company acquired, through a reverse triangular merger, all of the outstanding capital stock of MamaMancini’s in exchange for issuing MamaMancini’s shareholders (the “MamaMancini’s Shareholders”), pro-rata, a total of 20,054,000 shares of the Company’s common stock. Immediately after the Merger was consummated, and further to the Agreement, the majority shareholders and certain affiliates of the Company cancelled a total of 103,408,000 shares of the Company’s common stock held by them (the “Cancellation”). In consideration of the Cancellation of such common stock, the Company paid the Majority Shareholder in aggregate of $295,000 and 800,000 shares of common stock and released the other affiliates from certain liabilities. In addition, the Company has agreed to spinout to the Majority Shareholder all assets related to the Company’s real estate management business within 30 days after the closing. As a result of the Merger and the Cancellation, the MamaMancini’s Shareholders became the majority shareholders of the Company.
The condensed consolidated financial statements presented for all periods through and including April 30, 2014 are those of MamaMancini’s. As a result of this Merger, the equity sections of MamaMancini’s for all prior periods presented reflect the recapitalization described above and are consistent with the April 30, 2014 balance sheet presented for the Company.
Since the transaction is considered a reverse acquisition and recapitalization, the presentation of pro-forma financial information was not required.
Basis of Presentation
The condensed consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and include the accounts of the Company and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation.
F-5 |
MamaMancini’s Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
April 30, 2014
The unaudited financial information furnished herein reflects all adjustments, consisting solely of normal recurring items, which in the opinion of management are necessary to fairly state the financial position of the Company and the results of its operations for the periods presented. This report should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Company’s Form 10-K for the year ended December 31, 2013 filed on March 20, 2014 and the audited financial statements as of January 31, 2014 and for the one month period then ended filed with this Form 10-Q. The Company assumes that the users of the interim financial information herein have read or have access to the audited financial statements for the preceding fiscal year and that the adequacy of additional disclosure needed for a fair presentation may be determined in that context. Accordingly, footnote disclosure, which would substantially duplicate the disclosure contained in the Company’s Form 10-K for the year ended December 31, 2013 have been omitted. The results of operations for the interim periods presented are not necessarily indicative of results for the entire year ending January 31, 2015.
Note 2 – Summary of Significant Accounting Policies
Change of Year End
Effective January 13, 2014, MamaMancini’s Holdings, Inc. (the “Company”) changed its fiscal year-end date to January 31. The Company’s 2014 fiscal year commenced on February 1, 2014 and concludes on January 31, 2015. The Company changed its year end to be in conformity with a significant number of its retail customers that have a fiscal year end on or near January 31. This allows the Company to more accurately account for accrued discounts and promotions to these retailers.
Use of Estimates
The preparation of condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Such estimates and assumptions impact, among others, the following: allowance for bad debt, inventory obsolescence, the fair value of share-based payments.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.
Risks and Uncertainties
The Company operates in an industry that is subject to intense competition and change in consumer demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure.
The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the grocery industry, (ii) general economic conditions in the various local markets in which the Company competes, including the general downturn in the economy, and (iii) the volatility of prices pertaining to food and beverages in connection with the Company’s distribution of the product. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.
F-6 |
MamaMancini’s Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
April 30, 2014
Cash
The Company considers all highly liquid instruments purchased with a maturity of three months or less to be cash equivalents. The Company held no cash equivalents at April 30, 2014 and January 31, 2014.
The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits.
Accounts Receivable and Allowance for Doubtful Accounts
Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company generally does not require collateral to support customer receivables. The Company provides an allowance for doubtful accounts based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. The Company determines if receivables are past due based on days outstanding, and amounts are written off when determined to be uncollectible by management. The maximum accounting loss from the credit risk associated with accounts receivable is the amount of the receivable recorded, which is the face amount of the receivable net of the allowance for doubtful accounts. As of April 30, 2014 and January 31, 2014, the Company had reserves of $2,000.
Inventories
Inventories are stated at average cost using the first-in, first-out (FIFO) valuation method. Inventory was comprised of the following at April 30, 2014 and January 31, 2014:
April 30, 2014 | January 31, 2014 | |||||||
Finished goods | $ | 404,116 | $ | 159,829 |
Property and Equipment
Property and equipment are recorded at cost. Depreciation expense is computed using straight-line methods over the estimated useful lives.
Asset lives for financial statement reporting of depreciation are:
Machinery and equipment | 2-7 years |
Leasehold improvements | 3-10 years |
Fair Value of Financial Instruments
For purpose of this disclosure, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation. The carrying amount of the Company’s short term financial instruments approximates fair value due to the relatively short period to maturity for these instruments.
Stock Issuance Costs
Stock issuance costs are capitalized as incurred. Upon the completion of the offering, the stock issuance costs are reclassified to equity. Offering costs recorded to equity for the three months ended April 30, 2014 and March 31, 2013 and the one month ended January 31, 2014 were $222,327, $0 and $102,166, respectively.
F-7 |
MamaMancini’s Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
April 30, 2014
Research and Development
Research and development is expensed as incurred. Research and development expenses for three months ended April 30, 2014 and March 31, 2013 and the one month ended January 31, 2014 were $18,901, $3,143, and $8,477, respectively.
Shipping and Handling Costs
The Company classifies freight billed to customers as sales revenue and the related freight costs as cost of sales.
Revenue Recognition
The Company records revenue for products when all of the following have occurred: (1) persuasive evidence of an arrangement exists, (2) the product is delivered, (3) the sales price to the customer is fixed or determinable, and (4) collectability of the related customer receivable is reasonably assured. There is no stated right of return for products.
The Company meets these criteria upon shipment.
Expenses such as slotting fees and sales discounts are accounted for as a direct reduction of revenues as follows:
Three
Months Ended April 30, 2014 | Three
Months Ended March 31, 2013 | One
Month Ended January 31, 2014 | ||||||||||
Gross Sales | $ | 2,655,011 | $ | 1,931,473 | $ | 796,177 | ||||||
Less: Slotting, Discounts, Allowances | 71,862 | 159,309 | 20,925 | |||||||||
Net Sales | $ | 2,583,149 | $ | 1,772,164 | $ | 775,252 |
Cost of Sales
Cost of sales represents costs directly related to the production and manufacturing of the Company’s products. Costs include product development, freight, packaging, and print production costs.
Advertising
Costs incurred for producing and communicating advertising for the Company are charged to operations as incurred. Producing and communicating advertising expenses for the three months ended April 30, 2014 and March 31, 2013 and the one month ended January 31, 2014 were $761,999, $417,000 and $232,481, respectively.
F-8 |
MamaMancini’s Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
April 30, 2014
Stock-based Compensation
The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Accounting for Stock-Based Compensation” (“ASC 718”) which establishes financial accounting and reporting standards for stock-based employee compensation. It defines a fair value based method of accounting for an employee stock option or similar equity instrument. The Company accounts for compensation cost for stock option plans in accordance with ASC 718. The Company accounts for share-based payments to non-employees in accordance with ASC 505-50 “Accounting for Equity Instruments Issued to Non-Employees for Acquiring, or in Conjunction with Selling Goods or Services”.
The Company recognizes all forms of share-based payments, including stock option grants, warrants and restricted stock grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest.
Share-based payments, excluding restricted stock, are valued using a Black-Scholes option pricing model. Grants of share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Stock-based compensation expenses are included in cost of goods sold or selling, general and administrative expenses, depending on the nature of the services provided, in the Condensed Consolidated Statement of Operations. For the three months ended April 30, 2014 and March 31, 2013 and the one month ended January 31, 2014 share-based compensation amounted to $99,099, $0 and $45,681, respectively. Of the $99,099 recorded for the three months ended April 30, 2014, $94,927 was a direct cost of a stock offering and has been recorded as a reduction in additional paid in capital.
For the three months ended April 30, 2014, when computing fair value of share-based payments, the Company has considered the following variables:
● | The risk-free interest rate assumption is based on the U.S. Treasury yield for a period consistent with the expected term of the option in effect at the time of the grant. The risk free rate used had a range of 0.68%-1.71%. |
● | The Company has not paid any dividends on common stock since its inception and does not anticipate paying dividends on its common stock in the foreseeable future. Therefore the expected dividend rate was $0. |
● | The expected option term is computed using the “simplified” method as permitted under the provisions of Staff Accounting Bulletin (“SAB”) 110. The Company uses the simplified method to calculate expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term. |
● | The warrant term is the life of the warrant. |
● | The expected volatility was benchmarked against similar companies in a similar industry. The expected volatility used had a range of 144%-193%. |
● | The forfeiture rate is based on the historical forfeiture rate for the Company’s unvested stock options, which was 0%. |
F-9 |
MamaMancini’s Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
April 30, 2014
Earnings Per Share
Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during each period. Diluted earnings (loss) per share is computed by dividing net income (loss), adjusted for changes in income or loss that resulted from the assumed conversion of convertible shares, by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period.
The Company had the following potential common stock equivalents at April 30, 2014:
Common stock subscribed | 653,335 | ||
Common stock warrants, exercise price range of $1.00-$1.50 | 987,401 | ||
Common stock options, exercise price of $1.00 | 444,288 | ||
Total common stock equivalents | 2,085,024 |
The Company had the following potential common stock equivalents at March 31, 2013:
Common stock subscribed | -- | ||
Common stock warrants, exercise price range of $1.00 | 505,400 | ||
Common stock options, exercise price of $1.00 | 223,404 | ||
Total common stock equivalents | 728,804 |
Since the Company reflected a net loss during the three months ended April 30, 2014 and March 31, 2013, the effect of considering any common stock equivalents, would have been anti-dilutive. A separate computation of diluted earnings (loss) per share is not presented.
Income Taxes
Income taxes are provided in accordance with ASC No. 740, “Accounting for Income Taxes”. A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carryforwards. Deferred tax expense (benefit) results from the net change during the period of deferred tax assets and liabilities.
Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
Recent Accounting Pronouncements
The U.S. Financial Accounting Standards Board issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers, in May 2014. The amendments in this Update supersede the revenue recognition requirements in Topic 605, Revenue Recognition, including most industry-specific revenue recognition guidance throughout the Industry Topics of the Codification. In addition, the amendments supersede the cost guidance in Subtopic 605-35, Revenue Recognition—Construction-Type and Production-Type Contracts, and create new Subtopic 340-40, Other Assets and Deferred Costs—Contracts with Customers. In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This Accounting Standards Update is the final version of Proposed Accounting Standards Update 2011-230—Revenue Recognition (Topic 605) and Proposed Accounting Standards Update 2011–250—Revenue Recognition (Topic 605): Codification Amendments, both of which have been deleted. Accounting Standards Update 2014-09. The amendments in this Update are effectively for the Company for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. The Company is currently evaluating the effects of ASU 2014-09 on the condensed consolidated financial statements.
F-10 |
MamaMancini’s Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
April 30, 2014
Note 3 – Property and Equipment:
Property and equipment on April 30, 2014 and January 31, 2014 are as follows:
April 30, 2014 | January 31, 2014 | |||||||
Machinery and Equipment | $ | 1,038,953 | $ | 1,027,341 | ||||
Leasehold Improvements | 77,203 | 7,258 | ||||||
1,116,156 | 1,034,689 | |||||||
Less: Accumulated Depreciation | 71,399 | 56,662 | ||||||
$ | 1,044,757 | $ | 978,027 |
At April 30, 2014 and January 31, 2014 fixed assets in the amount of $854,509 and $826,340 were not in service.
Depreciation expense charged to income for the three months ended April 30, 2014 and March 31, 2013 and the one month ended January 31, 2014 amounted to $14,737, $3,260 and $4,141, respectively.
Note 4 – Investment in LLC
During 2011 the Company acquired a 34.62% interest in Meatball Obsession, LLC (“MO”) for a total investment of $27,032. This investment is accounted for using the equity method of accounting. Accordingly, investments are recorded at acquisition cost plus the Company’s equity in the undistributed earnings or losses of the entity. At December 31, 2011 the investment was brought down to $0 due to losses incurred by MO.
During 2013 the Company’s ownership interest in MO fell to 24% due to dilution.
During the three months ended April 30, 2014 the Company’s ownership interest in MO fell to 13% due to dilution.
Note 5 – Related Party Transactions
Supply Agreement
On March 1, 2010, the Company entered into a five year agreement with a Manufacturer (the “Manufacturer”) who is a related party. The Manufacturer is owned by the CEO and President of the Company. Under the terms of the agreement, the Company grants to the Manufacturer a revocable license to use the Company’s recipes, formulas, methods and ingredients for the preparation and production of Company’s products, for manufacturing the Company’s product and all future improvements, modifications, substitutions and replacements developed by the Company. The Manufacturer in turn grants the Company the exclusive right to purchase the product. Under the terms of the agreement the Manufacturer agrees to manufacture, package, and store the Company’s products and the Company has the right to purchase products from one or more other manufacturers, distributors or suppliers. The agreement contains a perpetual automatic renewal clause for a period of one year after the expiration of the initial term. During the renewal period either party may cancel the contract with written notice nine months prior to the termination date.
F-11 |
MamaMancini’s Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
April 30, 2014
Under the terms of the agreement if the Company specifies any change in packaging or shipping materials which results in the manufacturer incurring increased expense for packaging and shipping materials or in the Manufacturer being unable to utilize obsolete packaging or shipping materials in ordinary packaging or shipping, the Company agrees to pay as additional product cost the additional cost for packaging and shipping materials and to purchase at cost such obsolete packaging and shipping materials. If the Company requests any repackaging of the product, other than due to defects in the original packaging, the Company will reimburse the Manufacturer for any labor costs incurred in repackaging. Per the agreement, all product delivery shipping costs are the expense of the Company.
During the three months ended April 30, 2014 and March 31, 2013, the Company purchased substantially all of its inventory from the Manufacturer. At April 30, 2014 and January 31, 2014, the Company has a deposit on inventory in the amount of $762,743 and $598,987, respectfully, to this Manufacturer.
Due from Manufacturer – Related Party
During the three months ended April 30, 2014 and March 31, 2013, the Manufacturer received payments on behalf of the Company for the Company’s customer invoices and the Manufacturer incurred expenses on behalf of the Company for shared administrative expenses and salary expenses. In addition the Company made several unsecured loans to the Manufacturer during 2013. The loan to the Manufacturer is unsecured, does not bear interest and is due on demand. At April 30, 2014 and January 31, 2014 the amount due from the Manufacturer is as follows:
April 30, 2014 | January 31, 2014 | |||||||
Customer receipts collected by Manufacturer on behalf of Company | $ | 575,255 | $ | 575,255 | ||||
Loan to Manufacturer | 450,000 | 450,000 | ||||||
Shared expenses paid by Manufacturer on behalf of the Company | (266,394 | ) | (251,206 | ) | ||||
Due from Manufacturer | $ | 758,861 | $ | 774,049 |
Note 6 – Line of Credit
Effective January 3, 2014, the Company entered into a Sale and Security Agreement (the “Sale and Security Agreement”) with Faunus Group International, Inc. (“FGI”) to provide for a $1.5 million secured demand credit facility backed by its receivables and inventory (the “FGI Facility”). The Sale and Security Agreement has an initial three year term (the “Original Term”) and shall be extended automatically for an additional one year for each succeeding term unless written notice of termination is given by either party at least sixty days prior to the end of the Original Term or any extension thereof. The Company and certain of its affiliates also entered into guarantees to guarantee the performance of the obligations under the Sale and Security Agreement (the “Guaranty Agreements”). The Company also granted FGI a security interest in and lien upon all of the Company’s right, title and interest in and to all of its assets (as defined in the Sale and Security Agreement).
F-12 |
MamaMancini’s Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
April 30, 2014
Pursuant to the FGI Facility, FGI can elect to purchase eligible accounts receivables (“Purchased Accounts”) up to 70% of the value of such receivables (retaining a 30% reserve). At FGI’s election, FGI may advance the Company up to 70% of the value of any Purchased Accounts, subject to the FGI Facility. Reserves retained by FGI on any Purchased Accounts are expected to be refunded to the Company net of interest and fees on advances once the receivables are collected from customers. The interest rate on advances or borrowings under the FGI Facility will be the greater of (i) 6.75% per annum and (ii) 2.50% above the prime rate. Any advances or borrowings under the FGI Facility are due on demand.
The Company also agreed to pay to FGI monthly collateral management fees of 0.42% of the average monthly balance of Purchased Accounts. The minimum monthly net funds employed during each contract year hereof shall be $500,000. Additionally, the Company paid FGI a one-time facility fee equal to 1% of the FGI Facility upon entry into the Sale and Security Agreement.
Note 7 – Concentrations
Revenues
During the three months ended April 30, 2014, the Company earned revenues from three customers representing approximately 29%, 14% and 10% of gross sales. During the three months ended March 31, 2013, the Company earned revenues from five customers representing approximately 27%, 17%, 14%, 11% and 10% of gross sales. During the one month ended January 31, 2014, three customers represented 18%, 15% and 10% of gross sales.
Cost of Sales
For the three months ended April 30, 2014 and March 31, 2013 and the one month ended January 31, 2014, one vendor (a related party) represented 100% of the Company’s purchases.
Accounts Receivable
As of April 30, 2014, two customers represented approximately 33% and 10% of total gross accounts receivable. As of January 31, 2014, one customer represented approximately 24% of total gross accounts receivable.
Note 8 – Stockholders’ Equity
(A) Common Stock Transactions
During January 2014, the Company sold 300,000 shares of common stock to investors in exchange for $450,000 in proceeds in connection with the private placement of the Company’s stock. The shares were issued in March 2014.
In connection with the private placement the Company incurred fees of $102,166 consisting of $58,500 in cash and 30,000 warrants with a fair value of $43,666.
F-13 |
MamaMancini’s Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
April 30, 2014
Common Stock Subscribed
During March 2014, the Company sold 236,667 shares of common stock to investors in exchange for $355,000 in proceeds in connection with the private placement of the Company’s stock. The shares were not issued as of April 30, 2014.
In connection with the private placement the Company incurred fees of $80,536 consisting of $46,150 in cash and 23,667 warrants with a fair value of $34,386.
During April 2014, the Company sold 416,668 shares of common stock to investors in exchange for $625,001 in proceeds in connection with the private placement of the Company’s stock. The shares were not issued as of April 30, 2014.
In connection with the private placement the Company incurred fees of $141,791 consisting of $81,250 in cash and 41,667 warrants with a fair value of $60,541.
(B) Options
The following is a summary of the Company’s option activity:
Options | Weighted Average Exercise Price | |||||||
Outstanding – January 1, 2013 | 223,404 | $ | 1.00 | |||||
Exercisable – January 1, 2013 | - | $ | - | |||||
Granted | 318,000 | $ | 1.00 | |||||
Exercised | - | $ | - | |||||
Forfeited/Cancelled | - | $ | - | |||||
Outstanding – December 31, 2013 | 541,404 | $ | 1.00 | |||||
Exercisable – December 31, 2013 | 428,845 | $ | 1.00 | |||||
Granted | - | $ | - | |||||
Exercised | - | $ | - | |||||
Forfeited/Cancelled | - | $ | - | |||||
Outstanding – January 31, 2014 | 541,404 | $ | 1.00 | |||||
Exercisable – January 31, 2014 | 434,177 | $ | 1.00 | |||||
Granted | - | $ | 1.00 | |||||
Exercised | - | $ | - | |||||
Forfeited/Cancelled | - | $ | - | |||||
Outstanding – April 30, 2014 | 541,404 | $ | 1.00 | |||||
Exercisable – April 30, 2014 | 444,288 | $ | 1.00 |
F-14 |
MamaMancini’s Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
April 30, 2014
Options Outstanding | Options Exercisable | |||||||||||||||||
Range
of | Number Outstanding | Weighted
Average Remaining Contractual Life (in years) | Weighted
Average Exercise Price | Number Exercisable | Weighted
Average Exercise Price | |||||||||||||
$ | 1.00 | 541,404 | 3.52 years | $ | 1.00 | 444,288 | $ | 1.00 |
At April 30, 2014 and January 31, 2014, the total intrinsic value of options outstanding and exercisable was $1,061,152 and $1,082,808, respectively.
As of April 30, 2014, the Company has $4,172 in stock-based compensation related to stock options that is yet to be vested. The weighted average expensing period of the unvested options is .47 years.
(C) Warrants
The following is a summary of the Company’s warrant activity:
Warrants | Weighted
Average Exercise Price | |||||||
Outstanding – January 1, 2013 | 505,400 | $ | 1.00 | |||||
Exercisable – January 1, 2013 | - | $ | - | |||||
Granted | 386,667 | $ | 1.50 | |||||
Exercised | - | $ | - | |||||
Forfeited/Cancelled | - | $ | - | |||||
Outstanding – December 31, 2013 | 892,067 | $ | 1.22 | |||||
Exercisable – December 31, 2013 | 892,067 | $ | 1.22 | |||||
Granted | 30,000 | $ | 1.50 | |||||
Exercised | - | $ | - | |||||
Forfeited/Cancelled | - | $ | - | |||||
Outstanding – January 31, 2014 | 922,067 | $ | 1.22 | |||||
Exercisable – January 31, 2014 | 922,067 | $ | 1.22 | |||||
Granted | 65,334 | $ | 1.50 | |||||
Exercised | - | $ | - | |||||
Forfeited/Cancelled | - | $ | - | |||||
Outstanding – April 30, 2014 | 987,401 | $ | 1.24 | |||||
Exercisable – April 30, 2014 | 987,401 | $ | 1.24 |
F-15 |
MamaMancini’s Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
April 30, 2014
Warrants Outstanding | Warrants Exercisable | |||||||||||||||
Range
of | Number Outstanding | Weighted Average Remaining Contractual Life (in years) | Weighted
Average Exercise Price | Number Exercisable | Weighted Average Exercise Price | |||||||||||
$1.00-$1.50 | 987,401 | 3.81 years | $ | 1.24 | 987,401 | $ | 1.24 |
At April 30, 2014 and January 31, 2014, the total intrinsic value of warrants outstanding and exercisable was $1,694,305 and $1,635,801, respectively.
Note 9 – Commitments and Contingencies
Litigations, Claims and Assessments
From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm its business. The Company is currently not aware of any such legal proceedings or claims that they believe will have, individually or in the aggregate, a material adverse effect on its business, financial condition or operating results.
Licensing and Royalty Agreements
On March 1, 2010, the Company was assigned a Development and License agreement (“the Agreement”). Under the terms of the Agreement the Licensor shall develop for the Company a line of beef meatballs with sauce, Italian sausage with sauce and other similar Italian meats with sauces for commercial manufacture, distribution and sale (each a “Licensor Product” and collectively the “Licensor Products”). Licensor shall work with Licensee to develop Licensor Products that are acceptable to Licensee. Upon acceptance of a Licensor Product by Licensee, Licensor’s trade secret recipes, formulas methods and ingredients for the preparation and production of such Licensor Products (the “Recipes”) shall be subject to this Development and License Agreement.
The term of the Agreement (the “Term”) shall consist of the Exclusive Term and the Non-Exclusive Term. The 12-month period beginning on each January 1 and ending on each December 31 is referred to herein as an “Agreement Year.”
The Exclusive Term began on January 1, 2009 (the “Effective Date”) and ends on the 50th anniversary of the Effective Date, unless terminated or extended as provided herein. Licensor, at its option, may terminate the Exclusive Term by notice in writing to Licensee, delivered between the 60th and the 90th day following the end of any Agreement Year if, on or before the 60th day following the end of such Agreement Year, Licensee has not paid Licensor Royalties with respect to such Agreement Year at least equal to the minimum royalty (the “Minimum Royalty”) for such Agreement Year. Subject to the foregoing sentence, and provided Licensee has not breached this Agreement and failed to cure such breach in accordance herewith, Licensee may extend the Exclusive Term for an additional twenty five (25) years, by notice in writing to Licensor, delivered on or before the 50th anniversary of the Effective Date.
The Non-Exclusive Term begins upon expiration of the Exclusive Term and continues indefinitely thereafter, until terminated by Licensor due to a material breach hereof by Licensee that remains uncured after notice and opportunity to cure in accordance herewith, or until terminated by Licensee.
F-16 |
MamaMancini’s Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
April 30, 2014
Either party may terminate this Agreement in the event that the other party materially breaches its obligations and fails to cure such material breach within sixty (60) days following written notice from the non-breaching party specifying the nature of the breach. The following termination rights are in addition to the termination rights provided elsewhere in the agreement
● | Termination by Licensee - Licensee shall have the right to terminate this Agreement at any time on sixty (60) days written notice to Licensor. In such event, all moneys paid to Licensor shall be deemed non-refundable. |
Under the terms of the Agreement the Company is required to pay quarterly royalty fees as follows:
During the Exclusive Term and the Non-Exclusive Term the Company will pay a royalty equal to the royalty rate (the “Royalty Rate”), multiplied by Company’s “Net Sales”. As used herein, “Net Sales” means gross invoiced sales of Products, directly or indirectly to unrelated third parties, less (a) discounts (including cash discounts), and retroactive price reductions or allowances actually allowed or granted from the billed amount (collectively “Discounts”); (b) credits, rebates, and allowances actually granted upon claims, rejections or returns, including recalls (voluntary or otherwise) (collectively, “Credits”); (c) freight, postage, shipping and insurance charges; (d) taxes, duties or other governmental charges levied on or measured by the billing amount, when included in billing, as adjusted for rebates and refunds; and (e) provisions for uncollectible accounts determined in accordance with reasonable accounting methods, consistently applied.
The Royalty Rate shall be: 6% of net sales up to $500,000 of net sales for each Agreement year; 4% of Net Sales from $500,000 up to $2,500,000 of Net Sales for each Agreement year; 2% of Net Sales from $2,500,000 up to $20,000,000 of Net Sales for each Agreement year; and 1% of Net Sales in excess of $20,000,000 of Net Sales for each Agreement year.
In order to continue the Exclusive term, the Company shall pay a minimum royalty with respect to the preceding Agreement year as follows:
Agreement Year | Minimum
Royalty to be Paid with Respect to Such Agreement Year | |||
1st and 2nd | $ | - | ||
3rd and 4th | $ | 50,000 | ||
5th, 6th and 7th | $ | 75,000 | ||
8th and 9th | $ | 100,000 | ||
10th and thereafter | $ | 125,000 |
The Company incurred $78,630, $71,116 and $35,551 of royalty expenses for the three months ended April 30, 2014 and March 31, 2013 and the one month ended January 31, 2014, repsectively. Royalty expenses are included in general and administrative expenses on the Condensed Consolidated Statement of Operations.
Agreements with Placement Agents and Finders
(A) December 1, 2011
The Company entered into a Financial Advisory and Investment Banking Agreement with Spartan Capital Securities, LLC (“Spartan”) effective December 1, 2011 (the “Spartan Advisory Agreement”). Pursuant to the Spartan Advisory Agreement, Spartan will act as the Company’s exclusive financial advisor and placement agent to assist the Company in connection with a best efforts private placement (the “Financing”) of up to $6 million of the Company’s equity and/or debt securities and/or convertible instruments (the “Securities”).
F-17 |
MamaMancini’s Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
April 30, 2014
The Company upon closing of the Financing shall pay consideration to Spartan, in cash, a fee in an amount equal to 10% of the aggregate gross proceeds raised in the Financing. The Company shall grant and deliver to Spartan at the closing of the Financing, for nominal consideration, five year warrants (the “Warrants”) to purchase a number of shares of the Company’s Common Stock equal to 10% of the number of shares of Common Stock (and/or shares of Common Stock issuable upon exercise of securities or upon conversion or exchange of convertible or exchangeable securities) sold at such closing. The Warrants shall be exercisable at any time during the five year period commencing on the closing to which they relate at an exercise price equal to the purchase price per share of Common Stock paid by investors in the Financing or, in the case of exercisable, convertible, or exchangeable securities, the exercise, conversion or exchange price thereof. If the Financing is consummated by means of more than one closing, Spartan shall be entitled to the fees provided herein with respect to each such closing.
Along with the above fees, the Company shall pay up to $40,000 for expenses incurred by Spartan in connection with this Financing, together with cost of background checks on the officers and directors of the Company.
During the year ended 2012 the Company paid to Spartan fees of $505,400 and issued Spartan 505,400 five year warrants with an exercise price of $1.00.
(B) May 2, 2013
The Company entered into a second Financial Advisory and Investment Banking Agreement with Spartan Capital Securities, LLC (“Spartan”) effective May 2, 2013 (the “Spartan Advisory Agreement”). Pursuant to the Spartan Advisory Agreement, Spartan will act as the Company’s exclusive financial advisor and placement agent to assist the Company in connection with a best efforts private placement (the “Financing”) of up to $5 million of the Company’s equity and/or debt securities and/or convertible instruments (the “Securities”).
The Company upon closing of the Financing shall pay consideration to Spartan, in cash, a fee in an amount equal to 10% of the aggregate gross proceeds raised in the Financing and up to 3% of the aggregate gross proceeds raised in the Financing for expenses incurred by Spartan. The Company shall grant and deliver to Spartan at the closing of the Financing, for nominal consideration, five year warrants (the “Warrants”) to purchase a number of shares of the Company’s Common Stock equal to 10% of the number of shares of Common Stock (and/or shares of Common Stock issuable upon exercise of securities or upon conversion or exchange of convertible or exchangeable securities) sold at such closing. The Warrants shall be exercisable at any time during the five year period commencing on the closing to which they relate at an exercise price equal to the purchase price per share of Common Stock paid by investors in the Financing or, in the case of exercisable, convertible, or exchangeable securities, the exercise, conversion or exchange price thereof. If the Financing is consummated by means of more than one closing, Spartan shall be entitled to the fees provided herein with respect to each such closing.
The Company shall pay to Spartan a non-refundable monthly fee of $10,000 over a twelve to twenty four month period upon Spartan’s satisfaction of certain thresholds (raising of aggregate gross proceeds of $4.0mil-$5.0mil) outlined in the Spartan Advisory Agreement. On October 29, 2013 the Company entered into an amendment to the Agreement and the $10,000 monthly fee was cancelled.
F-18 |
MamaMancini’s Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
April 30, 2014
During the year ended December 31, 2013 the Company paid to Spartan fees of $650,000 and issued Spartan 333,333 five year warrants with an exercise price of $1.50.
(C) October 22, 2013
The Company entered into a third Financial Advisory and Investment Banking Agreement with Spartan Capital Securities, LLC (“Spartan”) effective October 22, 2013 (the “Spartan Advisory Agreement”). Pursuant to the Spartan Advisory Agreement, Spartan will act, for a minimum of twenty-four months from the date of the agreement, as the Company’s exclusive financial advisor and placement agent to assist the Company in connection with a best efforts private placement (the “Financing”) of up to $2.5 million of the Company’s equity and/or debt securities and/or convertible instruments (the “Securities”).
The Company upon closing of the Financing shall pay consideration to Spartan, in cash, a fee in an amount equal to 10% of the aggregate gross proceeds raised in the Financing and 3% of the aggregate gross proceeds raised in the Financing for expenses incurred by Spartan. The Company shall grant and deliver to Spartan at the closing of the Financing, for nominal consideration, five year warrants (the “Warrants”) to purchase a number of shares of the Company’s Common Stock equal to 10% of the number of shares of Common Stock (and/or shares of Common Stock issuable upon exercise of securities or upon conversion or exchange of convertible or exchangeable securities) sold at such closing. The Warrants shall be exercisable at any time during the five year period commencing on the closing to which they relate at an exercise price equal to the purchase price per share of Common Stock paid by investors in the Financing or, in the case of exercisable, convertible, or exchangeable securities, the exercise, conversion or exchange price thereof. If the Financing is consummated by means of more than one closing, Spartan shall be entitled to the fees provided herein with respect to each such closing.
The Company shall pay to Spartan a non-refundable monthly fee of $10,000 for the term of the agreement. Such monthly fee shall survive any termination of the Agreement.
During the year ended December 31, 2013 the Company paid to Spartan financing fees of $104,000 and issued Spartan 53,333 five year warrants with an exercise price of $1.50.
During the month ended January 31, 2014 the Company paid to Spartan financing fees of $58,500 and issued Spartan 30,000 five year warrants with an exercise price of $1.50.
During the three months ended April 30, 2014, the Company paid to Spartan financing fees of $127,400 and issued Spartan 138,463 five year warrants with an exercise price of $1.50.
Note 10 – Subsequent Events
The Company has evaluated all events that occurred after the balance sheet date through the date when the condensed consolidated financial statements were issued to determine if they must be reported.
F-19 |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Forward Looking Statements
This quarterly report on Form 10-Q and other reports (collectively, the “Filings”) filed by MamaMancini’s Holdings, Inc. (“MamaMancini’s” or the “Company”) from time to time with the U.S. Securities and Exchange Commission (the “SEC”) contain or may contain forward-looking statements and information that are based upon beliefs of, and information currently available to, the Company’s management as well as estimates and assumptions made by Company’s management. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. When used in the Filings, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” or the negative of these terms and similar expressions as they relate to the Company or the Company’s management identify forward-looking statements. Such statements reflect the current view of the Company with respect to future events and are subject to risks, uncertainties, assumptions, and other factors, including the risks contained in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013, filed with the SEC on March 20, 2014, relating to the Company’s industry, the Company’s operations and results of operations, and any businesses that the Company may acquire. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned.
Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.
Our financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). These accounting principles require us to make certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material differences between these estimates and actual results. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management’s judgment in its application. There are also areas in which management’s judgment in selecting any available alternative would not produce a materially different result. The following discussion should be read in conjunction with our consolidated financial statements and notes thereto appearing elsewhere in this report.
Plan of Operation
The Company plans to aggressively increase its distribution of products into new retail outlets in 2014. The Company has undertaken a national radio campaign on Sirius XM channels for a substantial portion of this year and also has commercials running on political talk radio. Social media activity has increased with Facebook, Twitter, Pinterest, YouTube, newsletter mailings, blogs, and helpful consumer content and special projects including a recipe bank of videos and MamaMancini’s contest and giveaways. Aggressive consumer merchandising activity, including virtual couponing, on-pack couponing, mail-in rebates, product demonstrations, and co-op retail advertising has commenced to increase sales to existing customers and new customers.
We believe that the ongoing introduction of the Company’s new line of all natural brand Slow Cooked Italian Sauce and various meatball and entrée products show great promise for additional product placements and sales in 2014 and thereafter. These products include Five Cheese Stuffed Meatballs, Chicken Parmigiana Style Stuffed Meatballs, Chicken Florentine Stuffed Meatballs, Gluten Free Beef and Turkey Meatballs, Antibiotic Free Beef and Turkey Meatballs, Bolognese Sauce, Mac n’ Mamas, and Orecchiette Pasta with Brocolli and Pork Meatballs. This line is available in bulk food service pack, retail packages in fresh and frozen varieties, and club store pack in fresh varieties. Additionally, the Company plans to continue expansion into various new retailers with placement of its existing all natural product line of Beef, Turkey, Pork and Chicken Meatballs and Sauce, as well as Marinara and Italian sauce with beef flavors.
5 |
Key sales personnel and a sales network of paid broker representatives are in place. Management is working diligently to solicit all major supermarket retailers, club stores and mass market accounts. Additionally, the Company has begun an effort to develop presentations to major entities in the sandwich, burger, and Italian sub quick-serve industry through a fee based consultant. The Company is also soliciting business in Canada and the Caribbean.
The Company owns 13% of the common equity of Meatball Obsession and is its exclusive supplier of meatball products. Meatball Obsession offers a fast service menu of take-out meatball offerings. The business plan of Meatball Obsession is to rapidly open more units at Universities in the fall of 2014 based upon its success this year. However, there is no guarantee that Meatball Obsession will perform up to its expectations or be able to open any more units in the future.
The Company increased its manufacturing source of supply in 2014 to meet an anticipated increased demand. Additions of high speed equipment and new production order flow has begun to occur. As sales increase, the Company expects that its packaging costs will decrease as it purchases longer runs of material and supplies but not guarantee that such packaging costs will decrease with the purchase of such materials or at all. The Company also expects that the labor costs component of the cost of goods sold will decrease in the later part of the year with higher speed equipment and order flow but cannot guarantee any such decrease in the labor costs.
The Company expects to have an operating loss in 2014 due to the investment in developing new and expanded business. These investments include slot fees to gain initial distribution, special marketing demo events to induce trial, major promotional campaigns for initial trial customers, and the cost of additional personnel or fee based marketing and sales support while this new business is developing.
The Company believes that the MamaMancini’s brand has potential for great market brand equity once established. We believe that MamaMancini’s products have the ability to grow into several areas of consumption by consumers such as frozen Italian specialties, frozen meat, fresh meat, prepared foods, hot bars, cold bars in delis, and sandwich sections of supermarkets and other retailers. In addition, we believe that MamaMancini’s products can be sold into food service channels, mass market, export or as a component of other products.
Results of Operations for the three months ended April 30, 2014 and March 31, 2013
The following table sets forth the summary income statement for the three months ended April 30, 2014 and March 31, 2013:
Three Months Ended | ||||||||
April 30, 2014 | March 31, 2013 | |||||||
Sales - Net of slotting fees and discounts(1) | $ | 2,583,149 | $ | 1,772,164 | ||||
Gross Profit | $ | 802,924 | $ | 490,062 | ||||
Operating Expenses | $ | (1,487,179 | ) | $ | (1,099,200 | ) | ||
Other Income (Expense) | $ | (16,634 | ) | $ | (2,250 | ) | ||
Net Loss | $ | (700,889 | ) | $ | (611,388 | ) |
6 |
Slotting fees are required in new placements with some, but not a majority of supermarket chains that the Company does business with. They are negotiated with each chain depending upon the expected return to the Company. We believe that we have successfully negotiated such slotting fees to a relatively low expense. We have taken into account future fees currently being negotiated in preliminary negotiations for new placements. We do not believe our size or financial limitations are an impediment to being able to pay such slotting fees. Slotting fee costs are an expense in growing the business as are other marketing and sales costs and the Company has accounted for these fees in assessing its estimated working capital for the next twelve months.
For the three months ended April 30, 2014 and March 31, 2013, the Company reported a net loss of $(700,889) and $(611,388), respectively. The change in net loss between the three months ended April 30, 2014 and March 31, 2013 was primarily attributable to following significant events:
● | The Company commenced operations during 2010 and has experienced significant growth in sales for the comparable periods. The Company has sold into approximately 26,000 retail and grocery locations at April 30, 2014 as compared to approximately 16,000 at March 31, 2013. The Company has reinvested proceeds to further develop brand awareness. |
● | Advertising and promotional expense increased by $295,000. |
● | Stock-based compensation expense increased by $4,000. |
● | Trade show and travel expenses increased by $6,400. |
● | Commission expenses increased by $27,800. |
● | Royalty expenses increased by $7,500. |
● | Postage and freight increased by $42,400. |
● | Insurance expense increased $8,400. |
● | Depreciation expense increased $11,500. |
● | Marketing research and social media costs increased by $40,200. |
● | Product development costs increased by $15,800. |
● | Professional fees decreased by $23,200. |
● | Payroll and related expenses decreased by $34,000. |
Sales: Sales, net of slotting fees and discounts increased by approximately 46% to $2,583,149 during the three months ended April 30, 2014, from $1,772,164 during the corresponding period ended March 31, 2013. The increase in sales is primarily related to the Company executing on their expansion strategy. The Company has sold into approximately 26,000 retail and grocery locations at April 30, 2014 as compared to approximately 16,000 at March 31, 2013. The Company commenced operations during 2010.
Gross Profit: The gross profit margin increased by approximately 3% from 28% for the three months ended March 31, 2013 to 31% for the three months ended April 30, 2014. This increase is primarily attributable to an improved product mix as well as decreased slotting fees and discounts.
7 |
Operating Expenses: Operating expenses increased by 35% during the three months ended April 30, 2014, as compared to the three months ended March 31, 2013. The $387,979 increase in operating expenses is primarily attributable to the following approximate increases in operating expenses:
● | Advertising and promotional expenses of $295,000 related to a new radio advertising campaign and special promotions; | |
● | Stock-based compensation of $4,000 as a result of stock options expensed during the period; | |
● | Trade show and travel expenses of $6,400 related to the increased cost of more members of the Company traveling and attending more trade shows as sales increased; | |
● | Commission expenses of $27,800 related to increased sales; | |
● | Royalties of $7,500 related to increased sales; | |
● | Postage and freight of $42,400 due to higher sales slightly offset by some customers picking up their product in lieu of having it shipped to them; | |
● | Insurance expenses of $8,400 related to increases in insurance coverage and premiums; | |
● | Depreciation expense of $11,500 due to new fixed asset purchases during the period; | |
● | Amortization expense of $4,100 related to the closing costs incurred on the Company’s line of credit; | |
● | Marketing research and social media costs increased by $40,200 due to the Company electing to spend more on market research and social media; and | |
● | Product development costs increased by $15,800 due to the Company expanding its line of products. |
These expense increases were offset by decreases in the following expenses:
● | Professional fees of $23,200 due to a decrease in legal expenses and professional fees which were offset by an increase in fees to an investment banker and financial consultants related to equity raises; | |
● | Payroll and related expense of $34,300 as compensation to a reduction in executive sales personnel; and | |
● | Public relations expenses of $18,000 because the Company no longer needed the exposure to enhance sales; and |
Other Income (Expense): Other expenses increased by $14,384 to $(16,634) for the three months ended April 30, 2014 as compared to $(2,250) during the three months ended March 31, 2013. For the three months ended April 30, 2014, other expenses consisted of $16,634 in interest expense incurred on the Company’s line of credit resulting from the FGI agreement signed in January 2014. For the three months ended March 31, 2013, other expenses consisted of $2,250 in interest expense incurred on the Company’s line of credit. The Company’s line of credit originally signed in October 2010 was repaid and cancelled on September 9, 2013.
Liquidity and Capital Resources
The following table summarizes total current assets, liabilities and working capital at April 30, 2014 compared to January 31, 2014:
Period Ended | ||||||||||||
April 30, 2014 | January 31, 2014 | Increase/(Decrease) | ||||||||||
Current Assets | $ | 4,303,017 | $ | 4,244,648 | $ | 58,369 | ||||||
Current Liabilities | $ | 787,610 | $ | 818,001 | $ | (30,391 | ) | |||||
Working Capital | $ | 3,515,407 | $ | 3,426,647 | $ | 88,760 |
As of April 30, 2014, we had working capital of $3,515,407 as compared to working capital of $3,426,647 as of January 31, 2014, an increase of $88,760. The increase in working capital is primarily attributable to an increase in accounts receivable, inventory, prepaid expenses, deposit with related party manufacturer partially, a decrease in accounts payable and accrued expenses and a decrease in the outstanding line of credit balance offset by a decrease in cash and a decrease in receivable from related party. During the three months ended April 30, 2014, the Company raised net proceeds of the $757,674 from the sale of 653,335 shares of common stock. During the one month ended January 31, 2014 the Company raised net proceeds of the $347,834 from the sale of 300,000 shares of common stock. All are a result of the Company executing on its expansion strategy.
Net cash used in operating activities for the three months ended April 30, 2014 and March 31, 2013 was $1,209,630 and $1,014,981, respectively. The net loss for the three months ended April 30, 2014 and March 31, 2013 was $700,889 and $611,388, respectively.
8 |
Net cash used in all investing activities for the three months ended April 30, 2014 was $81,467 as compared to $325,000 for the three months ended March 31, 2013. During the three months ended April 30, 2014, the Company paid approximately $81,500 to acquire new machinery and equipment. During the three months ended March 31, 2013, the Company paid $295,000 for the acquisition of a company and paid $30,000 for a loan to a related party.
Net cash provided by all financing activities for three months ended April 30, 2014 was $829,145 as compared to $0 for the three months ended March 31, 2013. During the three months ended April 30, 2014 the Company raised net proceeds of the $852,601 from the sale of common stock which was offset by $4,485 paid for debt issuance costs and net cash of $18,971 paid for transactions pursuant to the line of credit agreement. During the three months ended March 31, 2013, the Company did not have any financing activities.
The Company believes that our existing available cash along with estimated net proceeds from the issuance of securities during January 2014 and the first quarter of 2014 in addition to the line of credit entered into in January 2014 will enable the Company to meet the working capital requirements for at least 12 months. (See Note 6 to the condensed consolidated financial statements related to the line of credit). The estimated working capital requirement for the next 12 months is $2,200,000 with an estimated burn rate of $183,000 per month. The Company continues to explore potential expansion opportunities in the industry in order to boost sales while leveraging distribution systems to consolidate lower costs.
As reflected in the accompanying condensed consolidated financial statements, the Company has a net loss and net cash used in operations of $700,889 and $1,209,630, respectively, for the three months ended April 30, 2014.
The ability of the Company to continue its operations is dependent on Management’s plans, which include the raising of capital through debt and/or equity markets with some additional funding from other traditional financing sources, including term notes, until such time that funds provided by operations are sufficient to fund working capital requirements. The Company may need to incur additional liabilities with certain related parties to sustain the Company’s existence.
The Company may require additional funding to finance the growth of its current and expected future operations as well as to achieve its strategic objectives. There can be no assurance that financing will be available in amounts or terms acceptable to the Company, if at all. In that event, the Company would be required to change its growth strategy and seek funding on that basis, though there is no guarantee it will be able to do so.
In the event that we are unable to generate adequate revenues to cover expenses and cannot obtain additional financing in the near future, we may seek protection under bankruptcy laws. During the month ended January 31, 2014 and the three months ended April 30, 2014, Management raised capital through equity financings. The Company intends to utilize the capital in order to further advertise and market the Company’s brand and to assist in penetrating additional distribution channels.
Recent Accounting Pronouncements
Our condensed consolidated financial statements and related public financial information are based on the application of accounting principles generally accepted in the United States (“GAAP”). GAAP requires the use of estimates; assumptions, judgments and subjective interpretations of accounting principles that have an impact on the assets, liabilities, revenues and expense amounts reported. These estimates can also affect supplemental information contained in our external disclosures including information regarding contingencies, risk and financial condition. We believe our use of estimates and underlying accounting assumptions adhere to GAAP and are consistently and conservatively applied. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ materially from these estimates under different assumptions or conditions. We continue to monitor significant estimates made during the preparation of our financial statements.
9 |
Critical Accounting Policies
Our condensed consolidated financial statements and related public financial information are based on the application of accounting principles generally accepted in the United States (“GAAP”). GAAP requires the use of estimates; assumptions, judgments and subjective interpretations of accounting principles that have an impact on the assets, liabilities, revenues and expense amounts reported. These estimates can also affect supplemental information contained in our external disclosures including information regarding contingencies, risk and financial condition. We believe our use of estimates and underlying accounting assumptions adhere to GAAP and are consistently and conservatively applied. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ materially from these estimates under different assumptions or conditions. We continue to monitor significant estimates made during the preparation of our financial statements.
Our significant accounting policies are summarized in Note 2 of our condensed consolidated financial statements. While all these significant accounting policies impact our financial condition and results of operations, we view certain of these policies as critical. Policies determined to be critical are those policies that have the most significant impact on our financial statements and require management to use a greater degree of judgment and estimates. Actual results may differ from those estimates. Our management believes that given current facts and circumstances, it is unlikely that applying any other reasonable judgments or estimate methodologies would cause effect on our consolidated results of operations, financial position or liquidity for the periods presented in this report.
We believe the following critical accounting policies and procedures, among others, affect our more significant judgments and estimates used in the preparation of our consolidated financial statements:
Use of Estimates - The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Such estimates and assumptions impact, among others, the following: allowance for bad debt, inventory obsolescence, the fair value of share-based payments.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.
Stock-Based Compensation - The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Accounting for Stock-Based Compensation” established financial accounting and reporting standards for stock-based employee compensation. It defines a fair value based method of accounting for an employee stock option or similar equity instrument. The Company accounts for compensation cost for stock option plans in accordance with ASC 718. The Company accounts for share based payments to non-employees in accordance with ASC 505-50 “Accounting for Equity Instruments Issued to Non-Employees for Acquiring, or in Conjunction with Selling, Goods or Services”.
The Company recognizes all forms of share-based payments, including stock option grants, warrants and restricted stock grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest.
Share-based payments, excluding restricted stock, are valued using a Black-Scholes option pricing model. Share-based payment awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Stock-based compensation expenses are included in cost of goods sold or selling, general and administrative expenses, depending on the nature of the services provided, in the condensed consolidated Statement of Operations.
10 |
When computing fair value of share-based payments, the Company has considered the following variables:
● | The risk-free interest rate assumption is based on the U.S. Treasury yield for a period consistent with the expected term of the option in effect at the time of the grant. |
● | The Company has not paid any dividends on common stock since its inception and does not anticipate paying dividends on its common stock in the foreseeable future. |
● | The expected option term is computed using the “simplified” method as permitted under the provisions of Staff Accounting Bulletin (“SAB”) 110. |
● | The warrant term is the life of the warrant. |
● | The expected volatility was benchmarked against similar companies in a similar industry. |
● | The forfeiture rate is based on the historical forfeiture rate for the Company’s unvested stock options, which was 0%. |
Revenue Recognition - The Company follows the guidance of the Securities and Exchange Commission’s Staff Accounting Bulletin No. 104 for revenue recognition and records revenue when all of the following have occurred: (1) persuasive evidence of an arrangement exists, (2) the product is delivered, (3) the sales price to the customer is fixed or determinable, and (4) collectability of the related customer receivable is reasonably assured. There is no stated right of return for products. Sales are recognized upon shipment of products to customers.
Advertising - Costs incurred for producing and communicating advertising for the Company are charged to operations as incurred.
Off Balance Sheet Arrangements:
We do not have any off-balance sheet arrangements, financings, or other relationships with unconsolidated entities or other persons, also known as “special purpose entities” (SPEs).
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We do not hold any derivative instruments and do not engage in any hedging activities.
Item 4. Controls and Procedures
(a) Evaluation of Disclosure Controls and Procedures
Based on evaluation as of the end of the period covered by this Form 10-Q, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(c) and 15d-15(e) under the Exchange Act) are not effective to ensure that information required to be disclosed by us in report that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the U.S. Securities and Exchange Commission’s rules and forms and to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.
(b) Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
11 |
We are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our company or any of our subsidiaries, threatened against or affecting our company, our common stock, any of our subsidiaries or of our companies or our subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.
There have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2013, filed with the SEC on March 20, 2014.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Other than previously reported on the Company’s Current Reports on Form 8-K, there have been no unregistered sales of equity securities for the quarter ended April 30, 2014.
Item 3. Defaults upon Senior Securities.
There has been no default in payment of principal, interest, sinking or purchase fund installment, or any other material default, with respect to any indebtedness of the Company.
Item 4. Mine Safety Disclosure.
Not applicable.
There is no other information required to be disclosed under this item which was not previously disclosed.
Exhibit No. | Description | |
31.1 | Certification of Principal Executive Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 302 of 2002* | |
31.2 | Certification of Principal Financial Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 302 of 2002* | |
32.1 | Certification of Principal Executive Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002* | |
32.2 | Certification of Principal Financial Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002* | |
101.INS | XBRL Instance Document** | |
101.SCH | XBRL Taxonomy Extension Schema Document** | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document** | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document** | |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document** | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document** |
* Filed herewith.
** Furnished herewith.
12 |
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
MAMAMANCINI’S HOLDINGS, INC. | ||
Date: June 12, 2014 | By: | /s/ Carl Wolf |
Name: | Carl Wolf | |
Title: | Chief Executive Officer | |
(Principal Executive Officer) | ||
(Principal Financial Officer) | ||
(Principal Accounting Officer) |
13 |